The Pharmacy500 is awarded to 500 supply chain businesses and associations that have made a significant impact on dispensing pharmacies in the U.S. over the previous year. These select 500 represent companies that are shaping the pharmacy landscape, driving operational excellence, and supporting exemplary patient care.
For the full list, selection criteria, and details, please visit www.rxinsider.com/the-Pharmacy500.
YARAL Pharma Inc. is the U.S. subsidiary of IBSA, a global pharmaceutical company headquartered in Switzerland. By focusing on people and innovating the ways they’re cared for, YARAL Pharma is proud to offer the same values and expertise of its parent company to the US market. Dedicated to ensuring access to affordable authorized generics (AGs) and complex generic medicines that enhance healthcare outcomes, YARAL Pharma offers its customers high-quality products across a range of therapeutic areas, continuity of supply, and a commitment to exceptional customer service.
This post is related to:
